According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is 0,71ย โฌ. In 2025 the company made an earnings per share (EPS) of -0,008793ย โฌ an increase over its 2024 EPS that were of -4,40ย โฌ.